Health Literacy and Digital Health in Cancer Patients. (LICAPA)

Institut Bergonié

Status: Completed

Conditions: Cancer

Treatments: Other: Questionnaires

Study type: Observational

Funder types: Other

Identifiers

NCT05070897

2021-A01725-36 (Other Identifier)

IB 2021-04

Details and patient eligibility

About

This is a multicentric, prospective, observational, transversal study, aiming to evaluate the health literacy of cancer patients using the approved French version of the Functional, Communicative and Critical Health Literacy (FCCHL) scale in 2 populations:

• Population A: patients age 65 and over treated in an oncology or oncogeriatric outpatient clinic, or seen in an oncology or oncogeriatric consultation.
• Population B: young patients age 18 to 64 treated in an oncology or outpatient clinic, or seen in an oncology consultation.

The following questionnaires:

• Approved French version of the FCCHL scale
• Questionnaire on the use of digital tools adapted from the questionnaire on digital tools,

will be completed once only. It will be completed by the participant during the oncology or oncogeriatric consultation or outpatient clinic appointment, in self-questionnaire mode or face to face, assisted if necessary by a family member or member of the medical team.

Enrollment: 1,518 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Man or woman.
2. Age ≥ 18 years.
3. Patient treated for cancer.
4. Patient who can read and understand French.
5. Patient seen in an oncology or oncogeriatric consultation or treated in an outpatient clinic.
6. Patient in treatment or about to start treatment that has been offered to them, from the announcement consultation to 2 years after the start of treatment

Exclusion criteria

1. Patient hospitalised for longer than 24 hours.
2. Patient with know cognitive impairment preventing them from answering the questionnaire.

Trial design

1,518 participants in 2 patient groups

Population A

Description:

65 years old and more

Treatment:

Other: Questionnaires

Population B

Description:

18 to 64 years old

Treatment:

Other: Questionnaires